Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.

Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.
复制标题

DOI:
10.1038/srep39190
复制
发表时间:
2016-12-19
期刊:
影响因子:
4.6
通讯作者:
Merajver SD
Merajver SD
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Allen SG;Chen YC;Madden JM;Fournier CL;Altemus MA;Hiziroglu AB;Cheng YH;Wu ZF;Bao L;Yates JA;Yoon E;Merajver SD

文献摘要

参考文献

被引文献

相似文献

炎症性乳腺癌(IBC)是乳腺癌中最致命的形式。所有的IBC患者都有淋巴结受累,三分之一的患者在诊断时已经有远处转移。这种转移倾向是IBC的标志,将其与低致死性非炎性乳腺癌(nIBC)区分开来。已经进行了遗传分析研究以区分IBC和nIBC,但尚未鉴定出IBC癌细胞特异性基因特征。我们假设,一个肿瘤的外在因素,特别是肿瘤相关的巨噬细胞,促进和有助于IBC的极端转移表型。为此,我们研究了巨噬细胞条件培养基(MCM)对IBC的影响。我们发现,两个IBC细胞系是超反应MCM相比,正常样乳腺癌和侵略性nIBC细胞系。我们进一步询问了IBC的高反应性MCM使用微流体迁移装置,它允许单个细胞迁移路径跟踪。我们发现MCM“启动”IBC细胞的细胞机制,使其响应于化学引诱物而变得极度迁移。我们确定MCM中的白细胞介素-6,-8和-10足以刺激这种增强的IBC迁移效应,并且已知的转移癌基因RhoC GTdR是增强迁移反应所必需的。
Inflammatory breast cancer (IBC) is the most lethal form of breast cancer. All IBC patients have lymph node involvement and one-third of patients already have distant metastasis at diagnosis. This propensity for metastasis is a hallmark of IBC distinguishing it from less lethal non-inflammatory breast cancers (nIBC). Genetic profiling studies have been conducted to differentiate IBC from nIBC, but no IBC cancer-cell-specific gene signature has been identified. We hypothesized that a tumor-extrinsic factor, notably tumor-associated macrophages, promotes and contributes to IBC’s extreme metastatic phenotype. To this end, we studied the effect of macrophage-conditioned media (MCM) on IBC. We show that two IBC cell lines are hyper-responsive to MCM as compared to normal-like breast and aggressive nIBC cell lines. We further interrogated IBC’s hyper-responsiveness to MCM using a microfluidic migration device, which permits individual cell migration path tracing. We found the MCM “primes” the IBC cells’ cellular machinery to become extremely migratory in response to a chemoattractant. We determined that interleukins −6, −8, and −10 within the MCM are sufficient to stimulate this enhanced IBC migration effect, and that the known metastatic oncogene, RhoC GTPase, is necessary for the enhanced migration response.
DOI: 10.1002/cncr.25165
发表时间: 2010-06-01
期刊: CANCER
影响因子: 6.2
作者:
Bertucci, Francois;Finetti, Pascal;Viens, Patrice
通讯作者: Viens, Patrice
DOI: 10.1093/annonc/mdt525
发表时间: 2014-02-01
期刊: ANNALS OF ONCOLOGY
影响因子: 50.5
作者:
Masuda, H.;Brewer, T. M.;Ueno, N. T.
通讯作者: Ueno, N. T.
DOI: 10.1158/1535-7163.mct-14-0607
发表时间: 2015-07
影响因子: 5.7
作者:
Burgos-Ojeda D;Wu R;McLean K;Chen YC;Talpaz M;Yoon E;Cho KR;Buckanovich RJ
通讯作者: Buckanovich RJ
DOI: 10.1002/jcb.25025
发表时间: 2015-06-01
影响因子: 4
作者:
Joglekar, Madhura;Elbazanti, Weam O.;van Golen, Kenneth L.
通讯作者: van Golen, Kenneth L.
DOI: 10.1093/jnci/dji172
发表时间: 2005-07-06
影响因子: 10.3
作者:
Hance, KW;Anderson, WF;Levine, PH
通讯作者: Levine, PH